Status:
COMPLETED
Pycnogenol for the Treatment of Lymphedema
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Lymphedema
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accu...
Eligibility Criteria
Inclusion
- \> 6 months from last surgical and/or radiation treatment to the affected axilla
- Unilateral lymphedema of the upper extremity
Exclusion
- May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this study
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00214032
Start Date
May 1 2002
End Date
January 1 2007
Last Update
October 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792